| NCT ID | NCT06326905 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | Quality of Life |
| Study Type | INTERVENTIONAL |
| Enrollment | 43 participants |
| Start Date | 2025-01-25 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 43 participants in total. It began in 2025-01-25 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist population. It consists of two phases- an open label pilot and a randomized waitlist control trial, and 3) pilot test the feasibility and acceptability for CAPABLE Transplant in symptom and waitlist specific metrics amongst low-income active kidney transplant waitlist candidates.
Eligibility Criteria
Inclusion Criteria: * Deceased Donor Waitlist * ≥18 years old * Community dwelling * Current Inactive status or active and had been inactive in the last 18 months for cardiovascular disease, frailty, obesity, social support, mental health, incomplete testing OR Active on the waitlist and low-income Exclusion Criteria: * Living Donor Waitlist * Severe cognitive impairment * Inactivity expected to last \> 3 months (eg cancer treatment) * \>4 hospitalizations in the last 12 months * Current home nursing, physical or occupational therapy
Contact & Investigator
Melissa Hladek, PhD
PRINCIPAL INVESTIGATOR
Johns Hopkins School of Nursing
Frequently Asked Questions
Who can join the NCT06326905 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Quality of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06326905 currently recruiting?
Yes, NCT06326905 is actively recruiting participants. Contact the research team at mhladek1@jh.edu for enrollment information.
Where is the NCT06326905 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT06326905 clinical trial?
NCT06326905 is sponsored by Johns Hopkins University. The principal investigator is Melissa Hladek, PhD at Johns Hopkins School of Nursing. The trial plans to enroll 43 participants.